Among the components of metabolic syndrome, abdominal obesity is characterized by a chronic low-grade systemic inflammation, involving increased plasma pro-inflammatory cytokine levels such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) [3,4]. The gene discussed is TNF; the disease is metabolic syndrome.